In recent news, famed tennis player and former world number one Simone Halep has been suspended for four years from professional tennis for two 'doping offences', the International Tennis Integrity Agency (ITIA) said on Tuesday.
The 31-year-old Romanian Tennis player was provisionally suspended from October 2022 after having tested positive for the blood-boosting substance Roxadustat at the 2022 US Open.
What Is Roxadustat?
Roxadustat serves two purposes. First, it is a legitimate treatment for anaemia and second, it can stimulate the production of haemoglobin and red blood cells. When used by athletes, it enhances their performance, leading to its prohibition by the World Anti-Doping Agency due to its classification as a blood-doping agent.
In sports, including tennis, the biological passport system monitors an athlete's blood for the long term with the intent of identifying performance-boosting substances in the athlete's bloodstream, if there are any.
The 2022 US Open
At the 2022 US Open, Roxadustat was found in Simona Halep's urine sample, something Halep had provided as a part of the athlete's biological passport (ABP) system. According to Halep, she had accidentally consumed something that had Roxadustat in it.
According to ITIA's website, Halep was charged with two different offences by the Tennis Anti-Doping Programme (TADP), the first relating to Roxadustat being found in her urine through regular testing at the 2022 US Open, and the second being that Halep's ABP had 'irregularities', judging from over 51 blood samples.
Independent Tribunal
The two-time Grand Slam title champion's case was taken up by an independent tribunal, which met from June 28-29 of 2023 in London to investigate. According to ITIA's website, they heard from expert scientific witnesses on behalf of Halep and the ITIA, with the player also giving evidence directly to the panel as part of the proceedings.
On Monday, the tribunal found Halep guilty of having committed violations against the strict anti-doping laws of ITIA. Whilst the independent tribunal accepted that she could have taken a contaminated supplement, the volume of the roxadustat found in the positive sample did not line up with her story.
Halep had been provisionally suspended since October 2022, shortly after the US Open. Her temporary suspension has been included in the 4 years she's been suspended from tennis following the anti-doping violations, meaning that she will be able to return to tennis in 2026.
Reaction
Karen Moorhouse, Chief Executive Officer at the ITIA, said, "The ITIA has followed the proper processes as we would with any other individual - in accordance with the World Anti-Doping Code - fulfilling our purpose and responsibility to uphold the principle of fair competition, on behalf of the sport."
"The panel recognised that appropriate procedure had been followed within the written decision," she continued. “We do understand the significant public interest in these cases and remain committed to being as transparent as possible and the full decision will be published in due course,” Moorhouse elaborated further.
Halep plans to appeal the suspension. In a post on social media, she said that the tribunal had delayed its decision multiple times throughout the investigation and that she was shocked and disappointed by its decision.
Halep stated the Roxadustat found in her urine sample was a one-time thing, all her samples afterwards tested negative. She ended her statement by saying that she is continuing to train and do everything in her power to clear her name of these false allegations and return to the court.
Suggested Reading: Simona Halep Beats Sloane Stephens To Win French Open
/shethepeople/media/agency_attachments/iUYfaBbcMozaYLoGnoov.png)
Follow Us/shethepeople/media/media_files/TQdUxnbBTBXNdVVqzMIy.webp)